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CD98 (otherwise known as 4F2) is an integral membrane protein with multiple functions including amino acid transport, integrin activation,
cell fusion and cell activation. The molecular mechanisms coordinating these multiple functions remain unclear. We have studied CD98 heavy
chain (hc) function in a human placental trophoblast cell line (BeWo). We show that cross-linking of CD98hc by incubation of cells in the
presence of functional monoclonal antibodies causes cellular re-distribution of the protein from the cytoplasm to the plasma membrane as
measured by flow cytometry, western blotting and quantitative immuno-electron microscopy. The latter technique also indicated that CD98hc is
trafficked between cell surface and cytoplasmic pools in vesicles. Increased cell surface CD98 correlates with increased cellular fusion in BeWo
cells. In addition, we show reduced LAT 1 surface expression and neutral amino acid transport in the presence of the CD98 mabs. The results thus
suggest that the function of CD98 in cell fusion is distinct from its role in cellular nutrient delivery.
© 2006 Elsevier B.V. All rights reserved.Keywords: CD98; LAT 1; Cell fusion; Amino acid transport1. Introduction
Syncytialized trophoblast forms during implantation and is
then maintained at the villous maternal–fetal interface through-
out pregnancy. Understanding the mechanism that leads to
formation, maintenance and turnover of the syncytiotrophoblast
is clearly important for understanding both normal and
abnormal pregnancy (including pre-eclampsia). However, cell
fusion is a very rare event in cell biology and in humans is
typically observed only in the placenta (syncytiotrophoblast), in
skeletal muscle (striated muscle fibre) and in bone formation
(osteoclast) as well as during the fusion of gametes at
fertilization. It is also recognised pathologically as a mechanism
induced or required by some viruses to engage with host cells.
CD98 is a multifunctional transmembrane protein originally
found on the surface of activated T cells [1] but now known to
be present on virtually all cells, being expressed at particularly
high levels in actively proliferating tissue. Recent reports⁎ Corresponding author. Tel.: +44 7952868502; fax: +44 1865 272420.
E-mail address: paoladalton@yahoo.co.uk (P. Dalton).
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doi:10.1016/j.bbamem.2006.11.020describe the possible role of CD98 in the regulation of cell
differentiation, adhesion, growth, apoptosis and cancer devel-
opment [2–5]. Often these diverse cellular functions require
activation of integrin molecules but there is little information
about the exact mechanisms underlying them and more
generally of CD98 intracellular pathways [6–8].
The CD98 antigen forms a dimeric structure consisting of a
type 2 glycosylated integral membrane protein of around
80 kDa (heavy chain) and one of at least six proteins with
apparent molecular mass of 40 kDa (light chain) linked by
disulfide-bond. Depending on which light chain is part of the
heterodimer many amino acids, including several essential
amino acids, are transported across the plasma membrane in a
Na+-independent (system L, neutral amino acids transport) and
Na+-dependent (system y+L, neutral and cationic amino acid
transport) manner. The heavy chain is ubiquitous but variously
glycosylated according to the tissue of origin while the non-
glycosylated light chains are expressed differentially according
to tissue origin [9,10]. Transfection studies in mammalian cells
have indicated that while CD98hc can be expressed on the
plasma membrane on its own, trafficking of the light chain to
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apparently independently of disulfide linkage [7,11].
CD98 has been found to be identical to fusion regulatory
protein-1 (FRP-1) and its expression is necessary for virus-
induced cell fusion [12] and for osteoclast formation [13,14], it
is therefore of particular interest that CD98 is expressed on the
cytotrophoblasts and on the plasma membrane of the syncytio-
trophoblast, the site of exchange of nutrients, lipids and
minerals between the mother and the fetus, which results from
the fusion of the underlying cytotrophoblast cells [15,16].
While some antibodies against CD98/FRP-1 are known to
suppress virus-induced cell fusion and CD98-mediated cell
fusion of monocytes [13,17], others cross-linking CD98
stimulated cell aggregation and growth [3,4,18] indicating that
CD98/FRP-1 molecules are able to regulate cell fusion.
Forskolin, a cell permeable diterpenoid isolated from Coleus
forskohlii, stimulates adenylate cyclase activity to increase
intracellular cyclic adenosine monophosphate (cAMP) thus
activating cAMP-dependent protein kinase and other cAMP
receptor proteins. BeWo cells, a well established choriocarcinoma
cell line, can undergo fusion and morphological differentiation
similar to the formation of syncytiotrophoblast by the cytotropho-
blast in the placenta. Forskolin is known to increase this cellular
fusion in BeWo cells, and in other fusogenic cell lines [19–22].
Our laboratory has previously shown that manipulation of
CD98 cellular expression by antisense oligonucleotides [20] has
an effect on amino acid transport and on cellular fusion in BeWo
cells; in this paper we show that two monoclonal antibodies
against CD98 (mab4F2 and mabAHN18) can affect its surface
expression, cell differentiation and amino acid transport.
2. Materials and methods
2.1. Primary antibodies
4F2 was a generous gift from Dr. T. Sethi; AHN18 was from Chemicon
International. Goat anti-human CD98 (C-20), rabbit anti-human CD98 (H-300),
normal goat IgG and normal rabbit IgG (isotype-matched controls) were from
Santa Cruz Biotechnology Inc. Rabbit anti-rat LAT 1 (AHP735) and mouse IgG1
were from Serotec; 98C01 was from Stratech Scientific Ltd. and mouse IgG2a
was from Dako.
2.2. Secondary antibodies
Goat anti-rabbit IgG horseradish peroxidase-conjugated was from Dako.
Donkey anti-goat IgG fluorescein isothiocyanate-conjugated was from Jackson
immuno research laboratories and rabbit anti-goat IgG r-phycoerythrin-
conjugated was from Sigma. Protein A–15 nm gold complex was from British
Biocell.
2.3. Cell culture
BeWo cells were cultured at 37 °C as monolayers in F-12K Nutrient Mixture
(Kaighn's modification) supplemented with 10% fetal calf serum (FCS), 2 mM
L-glutamine (all GIBCO), 100 U ml−1 penicillin and 100 U ml−1 streptomycin
(Sigma) in an humidified atmosphere of 5% CO2 and 95% air. Confluent cells
were harvested by trypsinisation with trypsin-EDTA in HBSS w/o Ca2 and Mg2
(GIBCO), viable cells counted by the trypan blue (Sigma) method, resuspended
in serum-free medium and stained with either with 10 μl of vibrant DiO cell
labelling solution (1 mM, Molecular probes) per 106 /ml cells for 30 min at
37 °C or with MitoTracker Deep Red 633 (Molecular probes) at a concentrationof 25 nM per 106 /ml cells for 15 min 37 °C in the dark shaking gently. After
extensive washing with warm serum-free medium each group of cells was
resuspended in complete growthmedium and plated either on their own or in a 50%
mixture in six well culture plates (BD Falcon). When the cells reached 65–70%
confluence forskolin (Sigma) or vehicle (dimethyl sulfoxide, DMSO) was added in
fresh medium at a final concentration of 100 μM for 24 h, unless otherwise
indicated. In some wells, after 5 h of culture in forskolin or DMSO, 4F2 or AHN18
monoclonal antibody or the respective isotype matched control (mouse IgG2a or
IgG1) was added at a final concentration of 20 μg/ml (19 h).
2.4. Preparation of cell fractions, SDS-PAGE and Western Blotting
(WB)
Confluent cultures from six well plates were washed with ice-cold PBS and then
lysed bymanual agitation at 4 °C in ice-cold buffer containing 50mMTris–HCl, pH
7.4, 150 mMNaCl, 1 mMEDTA and 10 μl protease inhibitor mixture, (Sigma). We
used classical cell fractionation [23,24] to explore the distribution of CD98hc. Thus
the lysed cell homogenate (H) was centrifuged at low speed (800×g) for 15 min at
4 °C. Pellet (P1) was suspended in 200 μl buffer containing 50 mM Tris–HCl (pH
7.4), 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA and 10 μl
protease inhibitor mixture for 15 min on a rocker and then sonicated three times for
30 s. Using the same buffer, supernatant (S1) was sonicated three times for 30 s
(200 μl buffer) and clarified by centrifugation at high speed (17000×g) for 15 min at
4 °C, allowing us to collect supernatant S2. WB was then carried out on P1,
containing crude plasma membrane and heavy organelles, and S2, containing
purified membranes including small intracellular vesicles. For WB, precisely 10 μg
of protein was solubilised in NuPAGE sample buffer with reducing agent
(Invitrogen), warmed for 10 min at 75 °C and then run on 4–12% Novex Bis-Tris
NuPAGEgelswithMOPS running buffer (Invitrogen). The proteinswere transferred
to nitrocellulose membranes, blocked using 5% (w/v) non fat dry milk in 0.01 M
PBS (Sigma) with 0.05% (v/v) Tween 20 for 1 h at room temperature and then
incubated with rabbit anti human CD98 (H-300, 1:200) overnight at 4 °C. Goat anti
rabbit horseradish peroxidase-conjugated antibodywas used for secondary labelling.
Immunoreactive bands were identified by SIGMAFAST 3,3′-Diaminobenzidine
tablets (Sigma) according to the manufacturer's instructions. SeeBlue Plus2 pre-
stained protein standards were from Invitrogen. As a negative control we used a
mouse M1 cell homogenate (10 μg of protein).
2.5. Flow cytometry: surface staining on intact cells
Cells from six wells plates were detached with trypsin-EDTA (GIBCO).
Aliquots of 1×106 cells were washed in PBS and re-suspended in 250 μl of
FACS buffer (PBS, 1% fetal calf serum, 0.1%NaN3) with goat anti-human CD98
(C-20, 1:20) or isotype control IgG or no primary antibody. Cells were incubated
for 45min on ice, followed by threewasheswith FACS buffer. Sampleswere then
incubated with donkey anti-goat IgG fluorescein isothiocyanate-conjugated
(1:50) or rabbit anti-goat IgG r-phycoerythrin-conjugated secondary antibody
(1:20) for 45 min on ice and washed three times. Samples were finally
resuspended in FACS buffer and 2% paraformaldehyde (PFA) and analyzed by
flow cytometry using FACSCalibur (BD Biosciences) and Cell Quest software
and/or EPICS Altra (Beckman Coulter) and EXPO32 software.
2.6. Flow cytometry: surface and intracellular staining
Cells suspensions were fixed in 2% PFA for 20 min at room temperature,
washed once in PBS, permeabilised with 1% saponin in FACS buffer for 15 min
at room temperature and then stained following the surface staining protocol.
After the final wash samples were fixed again in 2% PFA before analysis.
2.7. Immunogold electron microscopy
Cells were prepared for electron microscopy by standard methods [25]. Briefly,
cell pellets were post-fixed in osmium tetroxide (1% w/v in 0.1 M sodium
phosphate buffer), contrasted with uranyl acetate (2% w/v in distilled water),
dehydrated through increasing concentrations of ethanol (70–100%) and embedded
in LR Gold resin (Agar Scientific UK). Ultra-thin sections (50–80 nm) were
prepared by use of a Reichert Ultracut S microtome and mounted on 200-mesh
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incubated with either goat anti-human CD98 (1:100) or rabbit anti-rat LAT 1 (1:50)
polyclonal antibody for 2 h and for 1 h with Protein A–15 nm gold complex. For
control sections, the primary antibody was omitted and replaced with a matching
dilution of the respective non-immune serum. Sections were then lightly
counterstained with uranyl acetate and lead citrate. All antibodies were diluted in
0.1 M phosphate buffer containing 1% w/v egg albumin. The sections were viewed
with a JEOL 1010 transmission electron microscope (JEOL, Peabody, MA, USA)
and representative micrographs were prepared.
The area of each cellular compartment of interest was determined by point
counting morphometry and the number of gold particles over each compartment
was counted.
2.8. Amino acid influx
After aspirating culture medium, each well was washed with pre-warmed
(37 °C) PBS and cells were depleted of intracellular amino acids by incubating in
PBS at 37 °C for 30 min to minimize any transtimulation effects. The influx of
amino acid was initiated by replacing the PBS with pre-warmed Na+-free PBS
containing 2 μM L-3H-leucine, followed by 3 min incubation at 37 °C. Na+-free
PBS was prepared by replacing NaCl, NaHCO3 and NaH2PO4 with choline
chloride, choline bicarbonate and KH2PO4, respectively. Other additions are
described in the figure legends. All uptake studies were conducted under initial rate
conditions. Following aspiration of isotope solution, cells were quickly washed with
ice-cold PBS containing 10 mM unlabelled L-leucine. Then 0.1 M NaOH and 0.1%
sodium dodecyl sulphate solution were added for solubilisation and aliquots were
taken for liquid scintillation counting and protein determination.
2.9. Statistical analysis
Results are presented as means±S.E. Significance of the differences
between means was assessed using two-tailed Student's t test. Values of p<0.05
were considered significant.
3. Results
3.1. Surface expression of CD98 increases significantly in cells
cultured in the presence of CD98 mabs 4F2 and AHN18
BeWo cells represent a useful tool for investigating the
molecular mechanism of syncytialisation in relation to the
expression of CD98 and its regulation.
We sought to correlate CD98 expression in BeWo cells with
fusogenicity; previously Kudo et al. [26] had observed a time-
dependent increase in CD98 mRNA in BeWo cells following
forskolin treatment. We determined levels of expression of
CD98 in BeWo cells cultured with/without forskolin by single
colour flow cytometry (FACS) and found a significant increase
of CD98 expression on intact BeWo cells after 24 h (Fig. 1A).
Monoclonal antibodies against different epitopes of CD98
have been used by several groups to either promote or inhibit
function of CD98 [3,4,13,14,17,18,27–31]. To date there is no
report of investigations on the effect of CD98 monoclonal
antibodies on BeWo cells either in relation to fusion or amino
acid transport.We cultured BeWo cells in the presence/absence of
monoclonal antibody 4F2 (IgG2), AHN18 (IgG1) and 98CO1
(IgM). While the latter (data not shown) or the isotype matched
negative controls did not have any effect in our system (Fig. 1A),
the two other monoclonal antibodies significantly increased
CD98 expression at the surface of intact cells both in control and
in forskolin treated cells (Fig. 1B, pooled data). Since in
permeabilized cells there was no significant change in the totalexpression (surface plus cytoplasm) of CD98 (Fig. 1C, pooled
data), this indicated that over the time course of these
experiments, culture of cells with the cross-linking antibodies
caused a shift in the relative cellular distribution of CD98 rather
than being the result of increased synthesis of CD98 protein.
3.2. Relocation of CD98 molecules in response to cross linking
with the CD98 mabs 4F2 and AHN18
Further studies were carried out on BeWo cells cultured for
24–26 h in medium containing DMSO (control cells) or
forskolin with/without 4F2 or AHN18 monoclonal antibodies
(19 h). For preliminary investigation we used western blotting
(WB). Fig. 2A shows the consistency of protein loading for each
of the conditions used. Immunoblots of cell fractions showed in
the presence of forskolin a redistribution of CD98hc following
mab4F2 incubation (Fig. 2B). The quantitation by densitometry
of these results is shown in supplementary file Fig. S1.
We therefore used immuno-electron microscopy to analyse
the cellular localisation of CD98 molecules. Although CD98
molecules were mostly individually distributed throughout the
cells, we noted pockets of clustering which were particularly
frequent either in forskolin (Fig. 3A) or in forskolin plus
monoclonal antibody-treated cells (Fig. 3B, C). Especially
interesting were some areas of almost circular clustering which
resembled vesicle assembly. However, since fixation proce-
dures, necessary for optimal antigen detection (for both CD98
and LAT 1, see Materials and methods) at the EM level are sub-
optimal for cellular morphology, at this stage we are unable to
prove vesicle involvement.
When the number of gold particles were determined with
respect to their cellular distribution in different cellular
compartments (membrane, cytoplasm, and nucleus) we observed
a marked increase of immunolabelling by gold particles in the
plasma membrane in BeWo cells previously cultured in the
presence of cross-linking antibody (Fig. 3D). This is in
agreement with the results obtained by both flow cytometry
and WB. However, the analysis of total CD98 immunoreactivity
per unit area also showed a two fold increase in BeWo cells
cultured in the presence of cross-linking antibody compared to
cells treated with forskolin only (data shown in supplementary
file Fig. S2). This is in apparent contrast with the total modest
increased observed with FACS (surface and intracellular
staining) but probably is due to both the different number of
cells examined with the two techniques (8 and 10,000) and the
inclusion of nuclear staining in the EM total. An alternative
explanation for the discrepancy relates to different accessibility
of CD98 epitopes with the different methods used.
3.3. Quantitation of cellular fusion
We used the Vibrant DiO cell-labelling solution (Fig. 4A), a
lipophilic tracer weakly fluorescent in water but highly
fluorescent and quite photostable when incorporated into
membranes, and Mitotracker deep red 633 (Fig. 4B), a cell-
permeant mitochondria selective dye, to uniformly label
suspended BeWo cells. Flow cytometry of a 50:50 mixed cell
Fig. 1. Single colour Flow cytometry for CD98. BeWo cells were cultured for 24 h in medium containing DMSO, Forskolin or Forskolin plus mab 4F2▪ or mab
AHN18▪ or isotype-matched negative control mouse IgG (19 h incubation) as described in Material and methods. After treatment, cells were labelled with goat anti-
human CD98 and rabbit anti-goat IgG conjugated with FITC or PE. (A) Histograms (flow cytometry) showing the percentage of cells positive for CD98 surface
expression in the different samples; notice that in the forskolin plus mab CD98 sample 60.2% of cells are positive compared with only 17.4% in its isotype-matched
IgG control. Single representative experiment. (B,C) Labelling of surface antigens on intact BeWo cells; (D) labelling of surface and intracellular antigens after cell
permeabilization. ▪Pooled results. Statistical analysis: two tailed paired t test; n=number of experiments, each experiment performed in duplicate or triplicate±SEM.
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and then cultured together allowed us to quantify cellular
fusion/stable aggregation represented by two positive cells
(Figs. 4C, 5). Two colour flow cytometry showed a statisticallysignificant increase of cellular fusion after forskolin treatment of
BeWo cells (p=0.0013, two tailed paired t test) which was
clearly enhanced, although not statistically significant, when the
cells were also cultured with CD98 mabs (Fig. 5A).
Fig. 2. Analysis of BeWo cell fractions. (A) SDS-PAGE, whole membrane after
transfer and staining with Ponceau Red. Lanes 1, 11 and 12 are protein
standards; lane 10 is a negative control cell line (M1). Lanes 2 and 3 are
respectively P1 and S2 from DMSO treated cells; lanes 4 and 5 are P1 and S2
from DMSO plus mab 4F2 treated cells; lanes 6 and 7 are P1 and S2 from
forskolin treated cells; lanes 8 and 9 are P1 and S2 from forskolin plus mab4F2
treated cells (see Materials and methods). Note the consistency of protein
loading (10 μg). (B) Immunoblot of data shown in (A) after incubation with
rabbit antihuman CD98 (Santa Cruz, 1:200), anti-rabbit-HRP and DAB. Arrow
indicates the 80 kDa band corresponding to CD98hc. Note the absence of CD98
immunoreactivity in the negative control (lane 10).
405P. Dalton et al. / Biochimica et Biophysica Acta 1768 (2007) 401–4103.4. CD98 and cellular fusion
We then employed a three colour flow cytometry protocol
by indirectly labelling the goat polyclonal anti human CD98
we routinely use to detect expression of CD98 molecules
with a secondary antibody conjugated with PE (phycoery-
thrin). Although partial spectral overlap between DiO and PE
required careful selection of appropriate compensation settings
we were able to show a parallel increase of CD98 expression
and cellular fusion on intact cells (Fig. 5B, C).
3.5. Anti-CD98 monoclonal antibodies affect LAT 1 surface
expression
CD98 has been shown to form heterodimers with several light
chains, each dimer considered the minimal functional unit for
transport activity. The heterodimer formed by CD98 and LAT 1
localizes at the cell surface and mediates the Na+-independenttransport of large neutral amino acids (L-type amino acid
transporter 1) [9]. It is generally assumed that the heavy chain
is mainly involved in the trafficking of the complex to the
plasma membrane, whereas the transport process itself is
catalysed by the light chain. We wondered if cross-linking of
CD98 with the monoclonal antibody could, by influencing LAT
1 trafficking to the cell surface, alter amino acid transport into
the cells. Fig. 6 shows the distribution of LAT 1 molecules in
the forskolin treated (Fig. 6A) and in the forskolin plus
monoclonal anti-CD98 treated (Fig. 6B) cell samples. Surpris-
ingly, when we counted the gold particles we observed a clear
decrease of LAT 1 membrane expression (Fig. 6C) (total LAT 1
immunoreactivity for cell area was also decreased following
exposure to the monoclonal anti-CD98, data shown in
supplementary file Fig. S3).
3.6. Cross-linking CD98 affects system L-amino acid transport
LAT 1, the light chain of system L, transports medium-size
and large neutral amino acids and does not show Na+
dependence. Since this transporter shows preference for neutral
non-polar amino acids such as L-leucine, we measured the
influx of 2 μM L-leucine in a Na+ free buffer into control and
forskolin treated BeWo cells, the latter cultured in the absence/
presence of CD98 monoclonal antibodies. In order to separate
the transport pathways contributing to total Na+-independent
flux, the synthetic amino acid 2-aminobicyclo-(2,2,1)-heptane-
2-carboxylic acid (BCH)was added at a concentration of 10mM.
The BCH-inhibitable component (i.e. system L-mediated influx
under the conditions used) was significantly reduced following
forskolin plus mab CD98 treatment (Fig. 6D). Exposure to
monoclonal antiCD98 significantly inhibits both expression
(Fig. 6C) and function (Fig. 6D); quantitatively the inhibition of
surface immunoreactivity is greater. Possible explanations
include (a) the inclusion of non-functional light chains in the
immune-EM assay; (b) the participation of other LAT isoforms
(e.g. LAT2).
4. Discussion
In this study we consider the functional relationship between
CD98 expression and fusion and amino acid transport by cross-
linking CD98 with monoclonal antibodies in a human tropho-
blast cell line.
Since the early 1990's monoclonal antibodies capable of
either enhancing or inhibiting virus induced fusion and entry in
host cells have been isolated. We are interested in investigating
the involvement of CD98 in trophoblast fusion, and for this
reason examined the effects of CD98 monoclonal antibodies in
the absence/presence of forskolin on BeWo cell fusion.
We used the monoclonal antibodies 4F2 and AHN-18 both
previously shown to have widespread effects in different
systems [18,32–34]. A third antibody, 981CO (or IPO-T10)
did not have any effect in our system and data are not included.
In cytotrophoblast primary cultures in vitro, the cellular
processes involved in syncytium formation are associated with a
concomitant increase in intracellular cAMP [35]. Previously
Fig. 3. Immuno-electron microscopy for CD98. (A) Electron micrographs of forskolin (×20K) and (B,C) forskolin and mab4F2 (×15K–20K) treated cells (24 h
culture, three representative fields). Single gold particles (thin arrows), clusters of gold particles on membrane process and cytoplasm (thick arrows). (D) Quantitation
of immunogold staining for CD98, 8 representative cells analysed: graph shows number of gold particles in different cellular compartment; ▪Pooled results. Statistical
analysis: paired t test, two tailed.
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cells, forskolin treatment and fluorescence-activated cell sorting
(FACS) to monitor the extent of cell fusion (syncytialisation).Fig. 4. Use of flow cytometry to detect cell fusion. Examples of BeWo cells labelled
50:50 mixture of single labelled cells after forskolin treatment (two positive cells in t
cytometer.Since one aim is to transfer and reproduce results from the
cytotrophoblast model to the primary cell line, where GFP type
transfection is not feasible, we used two well separatedwith (A) DiO (em.501 nm), (B) Mitotracker deep red 633 (em.665 nm) or (C) a
he upper right quadrant). Acquisition with EPICS Altra (Beckman Coulter) flow
Fig. 5. Flow cytometry of cell fusion. (A) Two colour flow cytometry for detection of fused (two positive) cells with/without monoclonal antibodies. BeWo cells were
pre-stained with DiO or Mitotracker deep red 633 dyes. Single colour cells or a 50:50 mixture of both cells were then cultured for 24 h in medium containing DMSO or
forskolin or forskolin plus mabs CD98 (19 h incubation). Statistical analysis: paired t test, two tailed. (B,C) Three colour Flow Cytometry for detection of fusion and
CD98 expression. Pre-stained cells, after forskolin and mabs CD98 treatment, were labelled with goat anti-human CD98 and rabbit anti-goat conjugated with PE
(em.575 nm) for simultaneous detection of fusion (B) and CD98 expression (C). ▪Pooled results. Graphs show data normalised to DMSO control (DMSO=10%). (B)
and (C) single representative experiments.
407P. Dalton et al. / Biochimica et Biophysica Acta 1768 (2007) 401–410fluorescent dyes to study cell fusion events in a similar fashion.
The dyes used have low cytotoxicity, are adequately (if not
perfectly) retained after fixation with 2% PFA and have well-Fig. 6. Distribution and function of LAT 1. (A,B,C) Immuno-electron microscopy f
mab4F2 (25K) treated cells (24 h culture, two representative fields). (C) Quantitation
compartments, 8 representative cells analysed. ▪Pooled results. Statistical analysis: pa
culture: in order to separate the transport pathways contributing to total Na+-indepen
acid (BCH), a system L-specific analogue, was added at a concentration of 10 mM. T
reduced following forskolin plus mabCD98 treatment. ▪Pooled results.separated emission spectra. Other studies similarly using flow
cytometry protocols with BeWo cells noted artefacts due to cell
aggregation after trypsinisation [21]. Our cells were harvestedor LAT 1: (A) Electron micrographs of forskolin (×25K) and (B) forskolin and
of immunogold staining for LAT 1: number of gold particles in different cellular
ired t test, two tailed. (D) 3H-L-Leucine (2 μM) influx in Na+ free buffer after 24
dent flux, the synthetic amino acid 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic
he BCH inhibitable component (i.e. system L-mediated influx) was significantly
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formation, although present, was limited; we found that gentle
but thorough re-suspension of our pellets, while causing
disruption of larger syncytia and elimination of the transient
aggregates due to the procedure, did maintain small syncytia
and stable aggregation of cells, which is the first step in
syncytialisation. We were easily able to analyse between 10,000
and 20,000 cells, which is not possible with normal routine
fluorescent microscopy, and results were reproducible; in
addition, in a preliminary study with primary cytotrophoblasts
these dyes did not have adverse effects (data not shown).
Finally, we examined the widespread transport system L, which
accounts for a sodium-independent exchange of large neutral amino
acids and is composed of theCD98heavy chain and theLAT1 light
chain, in the absence/presence of CD98 mabs.
Our results showed the following:
(1) A statistically significant, although limited, increase in
CD98 surface expression is already present after 24 h (by
FACS); however, the addition of either of the two
monoclonal antibodies against CD98, for the last 19 h
of the 24 h culture, caused an unexpected large increase of
CD98 membrane expression while total protein expres-
sion (both surface and intracellular) was not appreciably
raised. Although in this study we assumed (but have not
proved) dimerization of CD98 molecules through cross-
linking by monoclonal antibodies, other groups, investi-
gating CD98 stimulation of integrin dependent cell ad-
hesion or homotypic cell aggregation [4,34], have shown
with these antibodies that CD98 dimerization rather than a
direct physical effect of antibody binding to CD98 is
required for functional activities; significantly in these
experiments monovalent antibody fragments were unable
to stimulate function.
(2) The appearance in all samples, but in particular in
forskolin treated samples, of round clusters of immuno-
gold particles corresponding to CD98 molecules, both in
the cytoplasm and surface of the cells, and which strongly
suggested assembly in osmophilic vesicular structures (in
situ cellular localization of CD98 molecules by immuno-
electron microscopy). And, confirming previous experi-
ments with other techniques, a statistically significant
increase of CD98 plasma membrane distribution in the
presence of monoclonal antibodies. This finding again
points to a mechanism of activation/facilitation of
molecular re-distribution of CD98 in the presence of a
ligand. This raises the question ‘what could be the
physiological cross linker in vivo?’One possibility we are
currently investigating is that of galectin-3, previously
suggested as an endogenous linker for CD98. Moreover,
galectin-3 and CD98 have both been proposed as modu-
lators in a process leading to activation of integrin-
mediated adhesion, in fusion and in inflammatory
responses and both have been reported to induce calcium
influx [3,4,37–41].
(3) Forskolin treatment of BeWo cells causes a significant
increase in cellular fusion (plus 46% ±17); this is furtherincreased by 24% when the cells are also cultured with
CD98 mabs (by two colour FACS). More importantly,
increased cell fusion is matched by increased surface
expression of CD98 (by three colour FACS on the same
set of cells). This result strengthens the hypothesis that
CD98 is involved in BeWo cell fusion.
(4) The light chain LAT 1 is uniformly distributed in the cells,
without clusters and, at least as detected with our
antibody, much less abundant than the CD98 heavy
chain (∼1/4) both in control and in forskolin-treated cells
(in situ cellular localization of LAT 1 molecules by EM).
Intriguingly, cross-linking the heavy chain of the dimer
has a significant effect on the expression of the light
chain, an effect which is especially pronounced at the
plasma membrane, where little immunoreactivity is
detected. In addition, L-leucine influx is reduced in the
presence of the CD98 mabs. It has been suggested that the
light chain needs co-expression with the CD98 heavy
chain in order to reach the plasma membrane, and that the
extracellular domain of CD98 is necessary to ensure
proper translocation to the plasma membrane [7,11].
Expression levels of CD98 and LAT 1 are raised in many
primary human cancers; recently, Storey et al. [42] using
an adenoviral expression system showed that LAT 1
protein levels in hepatic cells could be increased three
fold, resulting in increased L-type amino acid transport.
The LAT 1 protein complexed with the CD98 heavy chain
was expressed on the cell surface and, at the same time
levels of the total CD98 protein complex were also
increased 2.4-fold. We hypothesize that, if CD98 is
necessary for LAT 1 trafficking to the plasma membrane
and if CD98 protein is more abundant than LAT 1 (a
likely pre-requisite for a molecule which forms different
heterodimers), increased levels of LAT 1 would draw free
cytosolic CD98 for trafficking to the cell surface
(producing the increased surface expression of both
exogenous LAT 1 and endogenous CD98 and the
increased Na+-independent system L mediated influx
observed). However, by ligating the heavy chain with its
monoclonal antibody we may interfere, by steric
hindrance, with the formation and stability of the
disulphide bond and/or non-covalent interactions between
the light and heavy chains, resulting in minimal
trafficking to the surface of the heterodimeric complex.
The free LAT 1 protein unable to bind the heavy chain
will eventually be broken down (as indicated by reduced
total levels), and neutral amino acid transport will
diminish as confirmed by our data on L-leucine influx.
In conclusion in this study we attempt to gain new insights
into the mechanism and functional impact of the CD98
heterodimeric protein; we suggest that CD98's two functions,
as mediator of cellular fusion and as a component of a family of
amino acid transporters, are distinct. This answers a hitherto
open question [43]. The limiting factor for both functions is
CD98 availability, albeit in the latter indirectly since it is
required only for LAT 1 surface localization.
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